MBI is the longest-running life sciences incubator in the Commonwealth. We help emerging life sciences companies advance from concept to clinical trials, create jobs, and promote economic development.
We help emerging life sciences companies advance from concept to clinical trials so they can bring lifesaving products to patients
Since 2000, MBI has incubated over 175 companies that have created over 1,025 jobs and raised over $1 billion
We support economic and workforce development to create a sustainable ecosystem in Massachusetts
A platform delivery company focusing on oncology, TransCode launched clinical trials while at MBI. The team closed a $30M IPO event while at our incubator and announced an additional $7M IPO shortly after graduating in 2022.
iVexSol, whose mission is to improve patients' lives by developing transformative vector production technologies, graduated from MBI in 2022 with 20+ employees and has raised $40M to date.
A veterinary therapeutics company focused on biopharmaceuticals that bring the best of human biotechnology to animal health, Invetx graduated from MBI in 2022 and has raised over $80M+.
MBI Receives U.S. Small Business Administration 2023 Growth Accelerator Fund Competition Stage Two Award
MBI will receive $150,000 in prize money to implement Growth Accelerator Partnerships to support innovation
Building with Biology: The Economic Acceleration of Central Massachusetts with a Bioindustrial Manufacturing Technology Hub
The Blackstone River Valley in Central Massachusetts was the birthplace of the industrial revolution. Nearly 250 years later, Worcester can be a leader in the new technology driven revolution of the next century, bioindustrial manufacturing. To spur this effort, a consortium of industry leaders and academic institutions, led by MBI, has applied for a grant from the U.S. EDA to accelerate this initiative and declare Worcester as a Regional Technology and Innovation Hub.